Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.

Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203 - Endothelial Mitogen - ECGS - J64516 - Alfa Aesar

J64516 Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203

CAS-Nummer
Synonyme
Endothelial Mitogen
ECGS

Größe Preis ($) Menge Verfügbarkeit
50mg 93,52
10x50mg 777,65
Zum Warenkorb hinzufügen Zur Angebotsanfrage hinzufügen Artikel anzeigen

Endothelial Cell Growth Supplement, bovine hypothalamus, BT-203

MDL
MFCD00146844

Chemische Eigenschaften

Form
Lyophilized powder

Anwendungen

Endothelial Mitogen (ECGS) is a partially purified preparation from bovine hypothalamus. Endothelial Mitogen was originally prepared to facilitate the growth and survival of human (or mammalian) vascular endothelial cells in vitro. Our ECGS is used to improve growth, supplement and/or reduce serum concentrations in cultures of endothelial cells, Balb/C-3T3 cells and in hybridoma cell cloning. Optimal concentration range is from 25-200µg/ml. Our ECGS does not contain streptomycin, which may be toxic to cellsEndothelial Cell Growth Supplement, bovine hypothalamus is an extract of bovine neural tissue containing growth promoting factors for vascular endothelial cells of mammalian origin. It has also been reported to be beneficial as a media supplement for the fusion and growth of hybridoma cells in monoclonal antibody production. In addition to this it is used for the culture of many other cell types, including human keratinocytes.

Bemerkungen

Store in a cool place. Incompatible with strong oxidizing agents.

Literaturverweise

O'Leary, A. P.; Fox, J. M.; Pullar, C. E. Beta-Adrenoceptor Activation Reduces Both Dermal Microvascular Endothelial Cell Migration via a cAMP-Dependent Mechanism and Wound Angiogenesis. J. Cell. Physiol. 2015, 230 (2), 356-365.

Sarmiento, D.; Montorfano, I.; Cerda, O.; Cáceres, M.; Becerra, A.; Cabello-Verrugio, C.; Elorza, A. A.; Riedel, C.; Tapia, P.; Velásquez, L. A.; Varela, D.; Simon, F. Increases in reactive oxygen species enhance vascular endothelial cell migration through a mechanism dependent on the transient receptor potential melastatin 4 ion channel. Microvasc. Res. 2015, 98, 187-196.

Weitere Referenzen

Harmonized Tariff Code
2937.19
TSCA
No

Empfohlen

  • H27004

    2-(2,2,2-Trimethylacetamido)benzeneboronic acid, 95%
  • J65815

    IL-1R Antagonist
  • H56532

    1-(2-Fluorobenzoyl)-4-methylpiperidine, 97%
  • H34277

    1-n-Butyl-4-oxo-1,4-dihydropyrido[1,2-a]pyrrolo[2,3-d]pyrimidine-2-carboxylic acid, 96%
  • B22265

    2-Methoxyethyl cyanoacetate, 98%

Kürzlich angesehen

Chemikalien

Life science

Metalle und Stoffe

Katalysatoren

Forschungs- und Laborbedarf